E. Åkerblom

发表

Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).

B. Samuelsson, A. Hallberg, A. Johansson, 2002, Bioorganic & medicinal chemistry.

Efficient and Selective Palladium-Catalysed C-3 Urea Couplings to 3,5-Dichloro-2(1H)-pyrazinones

F. Svensson, E. Åkerblom, A. Sandström, 2015 .

An immunoassay for histamine based on monoclonal antibodies.

E. Åkerblom, A. Hedin, A. Berglund, 1990, Journal of immunological methods.

Monomethoxypolyethylene glycol modified allergens.

E. Åkerblom, 1983, Arbeiten aus dem Paul-Ehrlich-Institut, dem Georg-Speyer-Haus und dem Ferdinand-Blum-Institut zu Frankfurt a.M.

Suppression of reaginic antibodies with modified allergens. IV. Induction of suppressor T cells by conjugates of polyethylene glycol (PEG) and monomethoxy PEG with ovalbumin.

E. Åkerblom, A. Sehon, W. Lee, 1981, International archives of allergy and applied immunology.

Induction of Basophilic Differentiation in the Human Basophilic Cell Line KU812

E. Åkerblom, S. Ahlstedt, K. Nilsson, 1988, Scandinavian journal of immunology.

B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol.

E. Åkerblom, J Röstin, A L Smeds, 2000, Bioconjugate chemistry.

Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocycles.

E. Åkerblom, P. Artursson, A. Karlén, 2014, Bioorganic & medicinal chemistry.

Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold.

E. Åkerblom, J. Neyts, A. Sandström, 2018, European journal of medicinal chemistry.

Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocket.

E. Åkerblom, P. Artursson, A. Karlén, 2014, Journal of medicinal chemistry.

Six new photolabile linkers for solid phase synthesis. 2. Coupling of various building blocks and photolytic cleavage

E. Åkerblom, 1998, Molecular Diversity.

Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.

E. Åkerblom, A. Karlén, A. Sandström, 2008, Bioorganic & medicinal chemistry.

Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.

B. Samuelsson, A. Hallberg, A. Johansson, 2003, Bioorganic & medicinal chemistry.

Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.

A. Hallberg, Yogesh Sabnis, A. Johansson, 2006, Bioorganic & medicinal chemistry.

P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis.

E. Åkerblom, G. Lindeberg, Aparna Vema, 2011, Bioorganic & medicinal chemistry.

Immunotherapy with monomethoxypolyethylene glycol modified allergens.

E. Åkerblom, S. Dreborg, 1990, Critical reviews in therapeutic drug carrier systems.

Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors.

E. Åkerblom, A. W. Richter, 1984, International archives of allergy and applied immunology.

Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.

A. Hallberg, A. Johansson, E. Åkerblom, 2001, Bioorganic & medicinal chemistry letters.

Resistance Profiling of Hepatitis C Virus Protease Inhibitors using Full-Length NS3

E. Åkerblom, A. Sandström, U. Danielson, 2007, Antiviral therapy.

Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.

E. Åkerblom, A. Sehon, L. Filion, 1981, International archives of allergy and applied immunology.

Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.

E. Åkerblom, E Akerblom, A W Richter, 1983, International archives of allergy and applied immunology.

2-Aminothiazolin-4-one and 2-Iminothiazolidine-4-one Derivatives. Part I. The Reaction of Chloroacetic Acid with N-Monoalkylthiourea.

L. Ehrenberg, E. Åkerblom, R. Blinc, 1967 .

Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.

B. Samuelsson, A. Hallberg, A. Johansson, 2004, Biochimica et biophysica acta.

Synthesis of 2-Alkoxy-1,3,4-thiadiazoles.

E. Åkerblom, R. Ryhage, R. Stevens, 1964 .

Stimulation of maturation of large immature histamine-containing basophilic cells from human peripheral blood, cord blood and bone marrow.

J. Denburg, E. Åkerblom, S. Ahlstedt, 1986, Immunology.

Structure–activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V

E. Åkerblom, Aparna Vema, A. Karlén, 2010, Antiviral therapy.

An improved procedure for N- to C-directed (Inverse) solid-phase peptide synthesis.

A. Hallberg, A. Johansson, E. Åkerblom, 2000, Journal of combinatorial chemistry.

Different Types of P1 Residues in Peptide-Based Inhibitors of Hepatitis C Virus Full-Length NS3 Protease

A. Hallberg, A. Johansson, A. Poliakov, 2001 .

Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region.

E. Åkerblom, G. Lindeberg, P. Artursson, 2014, ACS medicinal chemistry letters.

Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3

E. Åkerblom, A. Sandström, U. Danielson, 2007, The FEBS journal.